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Abstract: Metals are critical to neurodevelopment, and dysregulation in early life has been 
documented in autism spectrum disorder (ASD). However, underlying mechanisms and 
biochemical assays to distinguish ASD cases from controls remain elusive. In a nation-wide study 
of twins, we tested whether zinc-copper cycles, which regulate metal metabolism, are disrupted in 
ASD. Using novel tooth-matrix biomarkers that provide direct measures of fetal elemental uptake 
at 2-3-day resolution, we developed a predictive model to distinguish participants who would be 
diagnosed with ASD in childhood from those who did not develop the disorder. We replicated our 
findings in three independent studies in the US and UK. We show that three quantifiable 
characteristics of fetal and postnatal zinc-copper rhythmicity are altered in ASD; the average 
duration of zinc-copper cycles, regularity with which the cycles recur, and the number of complex 
features within a cycle. In all independent study sets and in the pooled analysis, zinc-copper 
rhythmicity was disrupted in ASD cases. In contrast to controls, in ASD cases the cycle duration 
was shorter (F=52.25, P<0.001), regularity was reduced (F=47.99, P<0.001) and complexity 
diminished (F=57.30, P<0.001). With two distinct classification models that used metal 
rhythmicity data, we achieved 90% accuracy in classifying cases and controls, with sensitivity to 
ASD diagnosis ranging from 85 to 100% and specificity ranging from 90 to100%. These findings 
suggest that altered zinc-copper rhythmicity precedes the emergence of ASD, and quantitative 
biochemical measures of metal rhythmicity distinguish ASD cases from controls. 
     
Introduction 
Autism spectrum disorder (ASD) affects 1 to 2% of the population in developed countries. 
Reports have shown that multiple nutrient elements and toxic metals are differentially absorbed 
and metabolized in children with ASD (1-3). However, the mechanisms underlying elemental 
dysregulation and ASD risk are not well understood, and it is not known if this elemental 
dysregulation is present in fetal and early postnatal life before first clinical symptoms manifest. 
In this study, we tested whether zinc-copper pathways were disrupted in ASD, and if quantitative 
measures of zinc-copper dynamics could provide a biochemical basis to distinguish ASD cases 
from controls. We selected zinc-copper cycles as our primary target for testing the dysregulation 
hypothesis because these are highly conserved in evolution, are essential for maintenance of 
health, and also exert homeostatic control over known neurotoxicants (4). Notable examples of 
disorders arising from perturbations of the metabolism of these metals include Wilson’s disease, a 
key component of which is copper dysregulation that leads to progressive neurological and 
cognitive dysfunction and psychosis-like symptoms also documented in adults with ASD (5). In 
Wilson’s disease, realigning the zinc-copper interaction via zinc supplementation increases the 
expression of the metal-binding protein metallothionein that helps regulate copper levels (6). 
Recently zinc-associated pathways have been implicated in ASD (4, 7, 8). For example, mutations 
in the gene coding for SHANK3, which is part of a zinc-mediated signaling system, are linked to 
increased ASD risk (9). 
Many physiologic processes follow cyclic patterns or rhythms that operate at a wide range of time 
intervals, from milliseconds (e.g., neuron firing) to hours (e.g., body temperature), days or 
circadian (e.g., sleep cycles), weeks, or longer (e.g., menstrual cycles) (10, 11). For any system in 
the body, multiple cycles operating at different timescales may interact, and the study of such 
processes requires methods that focus not solely on concentration, but rather on the dynamic 
changes over time (12, 13). Zinc and copper levels are not stationary in the human body, 
exhibiting a cyclic pattern (14-16). We, therefore, focused on their cyclic properties rather than 
single point measures of serum concentrations. We use the term ‘cycles’ to indicate time-
dependent rhythmic variation in the concentration of elements. Our methodology samples 
elemental concentrations in incremental zones of teeth (akin to growth rings in trees) at 
approximately 2 to 3 day intervals, which allows the identification of cyclical processes varying at 
an approximately 7- to 10-day period. Contrasting these cycles between ASD cases and controls 
offers a way to uncover system-wide dysregulations in zinc-copper rhythmicity. Furthermore, 
     
because zinc and copper pathways are central regulators of multiple metals, their disruption 
would have downstream effects including incomplete metabolism of other essential elements and 
toxic metals (17, 18). We, therefore, also studied the metabolic cycles of other metals during the 
fetal and early childhood periods (from the second trimester to approximately one year of age) 
(19, 20). To test our hypothesis, we applied the tooth biomarkers in four case-control samples; a 
discovery population of twins from Sweden and replication in two US case-control samples and a 
birth cohort from the UK. 
Results  
Dysregulation of Zinc-Copper Cycles in ASD 
Our primary hypothesis predicts dysregulation of zinc-copper cycles in ASD, as quantified by 
cycle duration, complexity, and regularity. The mean diagonal length (MDL) measures the 
duration of a cycle and was used in our study to detect fragmentation of zinc-copper cycles (Fig. 1 
and Supplementary Methods). We found that MDL for zinc-copper cycles was significantly 
reduced across all cohorts (F = 52.25, P < 0.001), reflecting an average reduction of 15% in ASD 
twins (Fig. 2A). We also detected a significant ASD*Study interaction (F = 3.83, P = 0.014), 
reflecting some across-study variability in the magnitude of ASD-related reductions, but post-hoc 
tests confirmed significantly reduced MDL in ASD cases in all populations studied (Sweden, F = 
38.05, P < 0.001; New York, USA, F = 8.07, P = 0.029; Texas, USA, F = 12.41, P = 0.005; UK, 
F = 8.57, P = 0.023). For additional details see Table S1.  
Zinc-copper cycles in ASD cases also exhibited significantly reduced entropy (a measure of 
biochemical network complexity) in contrast to non-ASD controls, who had more complex cycles 
(F = 57.3, P < 0.001, Fig. 2B). After correction for multiple comparisons, we found no evidence 
that this effect varied across populations; that is, the attenuation of entropy in ASD cases was 
consistent across studies.  
Finally, we found that determinism, a measure of cycle regularity and resistance to perturbation 
was significantly reduced in ASD patients (F = 47.99, P < 0.001, Fig. 2C).  As with entropy, we 
found that the ASD-related attenuation of determinism was consistent across populations.  
Accuracy of Elemental Dynamics for Classifying ASD 
Given the significant differences we observed between ASD cases and neurotypically developing 
controls across multiple dynamical features of elemental cycles, we implemented an ensemble 
machine learning classification method generalized from weighted quantile sum (WQS) 
regression (21) to gauge how the full range of cyclical features classify subjects as ASD cases or 
controls independently of their population of origin. Using optimal threshold criteria, this model 
was 90% accurate in predicting ASD cases, with 100% sensitivity for ASD diagnosis, 85% 
specificity to controls. Fig. 3A shows the classification performance of this model as applied to 
the holdout dataset (15% of data). To confirm that robust classification could be achieved 
independently of the predictive algorithm applied, we also implemented an alternative approach 
based on penalized logistic regression (LASSO). This approach achieved similar overall model 
accuracy (90%; model performance summarized in Fig. 3B), with slightly less sensitivity but 
improved specificity. Model performance relative to WQS is summarized in Fig. 3C; additional 
details on the construction of classification algorithms in presented in the Supplementary 
Materials.  
Discussion  
We tested the hypothesis that disruption of zinc-copper dynamics underlies the elemental 
dysregulation that has been observed in ASD (1-3). We used tooth matrix biomarkers to measure 
detailed temporal profiles of zinc, copper and other elements from the second trimester to 
approximately one year postnatally. To characterize the co-progression of zinc and copper cycles 
throughout early development, we used cross-recurrence quantification analysis (CRQA), a 
mathematical approach that originates in dynamical systems theory. We identified cycles varying 
on an approximately 10-day period, and found strong evidence for abnormalities in zinc-copper 
cycles in ASD characterized by shorter duration, lower complexity and less determinism. Further, 
we found that the integration of these dynamical features in an ensemble machine-learning 
algorithm, allowed a robust classification of ASD cases and controls, which we were able to 
replicate with similar accuracy with an alternative predictive algorithm based on penalized 
logistic regression. Taken together, these findings suggest that the normally well-coordinated and 
intricate metabolism of these essential elements is fragmented in ASD. 
Metals have long been implicated in autism (1-3). Early life exposure to toxic metals and 
deficiencies of nutritional elements have been linked with several adverse developmental 
outcomes frequently associated with ASD, including intellectual disability, and language, 
attentional and behavioral problems (22). Animal studies show that the effects of various metals 
on brain development could be mediated through dysregulation in neurotransmission, and 
alterations in frontal and subcortical brain structures (23), which have also been implicated in 
ASD (24). Here, we found that measures of metal rhythmicity were associated with ASD case 
status, but not metal concentrations. These data emphasize that the dysfunctions apparent in 
cyclical properties are not evident in raw measures of concentration, which highlights the utility 
of our approach. This does not suggest that elemental concentrations are not relevant to the 
etiology of ASD, as we have previously published findings linking elevated levels of several 
elements (25). That study dealt exclusively with a twin sample, however, and without the inherent 
control of genetic and environmental confounds in non-twins, those differences in elemental 
concentrations may not be apparent. 
Dynamic rhythms are central to human health and disease, and have been reported in many 
systems (12, 13). Notably, much research has been done on imprints of rhythms in mammalian 
teeth (26, 27), making naturally shed deciduous human teeth an ideal biomatrix to study the role 
of metal rhythmicity and its disruption in childhood disorders, as we have done here for ASD. A 
key feature of our approach is the focus on dynamic rhythms in the internal metabolism of 
essential elements and toxic metals, rather than solely relying on an exposure paradigm that 
emphasizes external environmental exposures. By doing so, we could identify disrupted zinc-
copper (and zinc-lead) cycles, even in populations where exposures were not excessive. In 
contrast to prior studies that have employed blood or urinary biomarkers to investigate cyclical 
elemental dynamics in humans over periods less than a week, our methods allowed a longitudinal 
analysis over a prolonged developmental period extending from the second trimester to 
approximately 1 year of age. An important consideration is that these differences in the 
developmental periods studied and temporal resolution between our study and those utilizing 
repeated blood or urine measurements, do not imply that the underlying processes being observed 
are dissimilar or unrelated; rather, we suggest that the cyclical processes we capture are 
superimposed on daily oscillations that have been previously described (14, 15). Independent of 
the duration of the cycles studied, we consistently found dysregulated cycle complexity and 
regularity in ASD cases across multiple replication samples, which bolsters our results against 
random measurement errors, and served as the basis of our classification analysis.     
Critically, the focus on elemental dynamics represents a novel theoretical perspective in the 
consideration of factors predictive of ASD. While the role of elemental exposures in ASD is well-
studied, previous investigations have considered primarily on the role of exposure intensities, i.e. 
biomarker concentrations. Our results provide a new perspective, in that the temporal 
organization of elemental assimilation, and the interaction of multiple elemental pathways, 
appears critical to the emergence of ASD. Importantly, this theoretical perspective, which we 
refer to as systemic elemental dysregulation (SED), opens new avenues for investigating 
elemental dysregulation in ASD and other disorders, and yields testable hypotheses for future 
investigations to pursue. For example, our finding of dysregulated zinc-copper rhythmicity 
suggests underlying dysregulation in mechanisms involved in zinc-copper metabolism, which will 
be pursued in future studies with in vivo animal models and in vitro induced pluripotent stem 
cells (iPSC), where experimental manipulation of zinc-copper dynamics is possible. Consistent 
with this, a recent study (28) identified zinc deficiency and attenuated zinc transporter expression 
in humans with autism-related mutations in the SHANK3 gene, consistent with the SEDs 
etiological perspective of dysregulated metabolic processes (3). Additionally, our results 
emphasize the need to investigate other diseases where elemental assimilation is known to play a 
role, for example ADHD, but has to-date been primarily studied through the lens of exposure 
intensity.  
We also studied other elements because disruption of zinc and copper cycles may have 
downstream effects including incomplete metabolism of other elements and toxic metals (17, 18). 
While we did not directly test biochemical pathways underlying interactions between zinc, copper 
and other elements, we observed alteration in the joint rhythmicity of zinc and lead characterized 
by smaller and less complex cycles (Fig. S1). Shorter and lower entropy interactions suggest that 
the regulatory effect of zinc on toxic metals, which is generally perceived as protective, is 
perturbed. We also found differences in other metals between cases and controls that were 
restricted to some but not all study samples (see Tables S1 and S2). This may be due to 
population-specific dynamics, such as differences in diet or exposure to pollution, which we have 
not analyzed in-depth here.  
Strengths of this study include the use of recently developed and validated methods to measure 
metals in teeth that provide detailed temporal profiles of elemental uptake during the fetal and 
early childhood periods. The use of population-derived discovery cohorts and the fact that our 
results could be replicated in ASD children from several geographical regions further bolsters the 
validity of our findings. Limitations include small discovery and replication populations, but 
together our sample size is approximately 200 participants, which was sufficient to detect and 
replicate significant elemental disruptions. Nonetheless, it is possible that other elements are also 
affected, which would only be detected with larger sample sizes. Our laser-based sampling 
method did not provide sufficient sampling points to separately study metal rhythmicity during 
the prenatal period from that observed after birth. Given that metal metabolism processes can 
incorporate toxic elements with similar chemical properties (cadmium, mercury among others), 
the dysregulatory mechanism described herein may also play a role in their well-described 
neurotoxicity. Furthermore, other neuroactive metal regulatory pathways such as iron and 
manganese deserve study as well.  
In conclusion, in a discovery set of twins, including monozygotic twins discordant for ASD, and 
three independent replication population samples, zinc-copper cycles were consistently altered in 
ASD. Furthermore, quantitative biochemical measures of the joint cyclic properties of zinc and 
copper accurately distinguished ASD cases from controls. 
Materials and Methods 
Study participants 
Our participants were recruited from four different studies being undertaken in three countries. 
Key characteristics of the studies are outlined in Table 1 and details of participant recruitment and 
ASD case ascertainment are provided in the Supplementary Methods. In brief, a discovery 
analysis was undertaken in the Roots of Autism and ADHD Twin Study in Sweden (RATSS), 
which is designed to investigate the genetic and environmental determinants of ASD. Twins are 
recruited from nationwide registries and by advertisements in Sweden (29). From the whole 
RATSS cohort, we collected and analyzed teeth from 75 participants (32 complete twin pairs and 
11 individuals from twin pairs whose sibling did not donate a tooth). This subsample constitutes 
26% of the RATSS cohort, and 50% of all participants in RATSS of tooth shedding age.  
For our primary replication analysis, we obtained teeth and supporting data from 25 ASD cases 
and 25 gender matched controls enrolled in a long-term pregnancy cohort in the UK - the Avon 
Longitudinal Study of Parents and Children (ALSPAC) (30). We undertook additional replication 
analysis by including ASD diagnosed individuals (N = 10) at an autism clinic in New York, USA, 
and their unaffected siblings (N = 8) (31). Finally, we enrolled a random sample of 25 cases and 
25 controls from a community-based study in Texas, USA – the Autism Tooth Fairy Project – that 
collects teeth and supporting data from parents through a community network (32). 
Laboratory Assessments 
Details of tooth collection protocols of each study population are provided in the Supplementary 
Materials. Our approach to measuring metals in teeth using laser ablation-inductively coupled 
plasma mass spectrometry (LA-ICP-MS) and assigning developmental times has been detailed 
elsewhere (33, 34). Briefly, teeth are sectioned and the neonatal line (a histological feature formed 
in enamel and dentine at the time of birth) and incremental markings are used to assign temporal 
information to sampling points. A New Wave Research NWR-193 (ESI, USA) laser ablation unit 
equipped with a 193nm ArF excimer laser was connected to an Agilent Technologies 8800 triple-
quad ICP-MS (Agilent Technologies, USA). Helium was used as a carrier gas from the laser 
ablation cell and mixed with argon via Y-piece before introduction to the ICP-MS. The system 
was tuned daily using NIST SRM 612 (trace elements in glass) to monitor sensitivity (maximum 
analyte ion counts), oxide formation (232Th16O+/232Th+, < 0.3%) and fractionation 
(232Th+/238U+, 100 ± 5%). The laser was scanned in dentine parallel to the DEJ from the 
dentine horn tip towards the tooth cervix. A pre-ablation scan was run to remove any surface 
contamination. Data were analyzed as metal to calcium ratios (e.g. 208Pb:43Ca) to control for any 
variations in the mineral content within a tooth and between samples. On average, each tooth was 
sampled at 152 locations, reflecting a sampling window for metal uptake of -113 to 214 days 
since birth, on average. LA-ICP-MS operating parameters are given in Table S3. 
Statistical analyses 
Traditional statistical approaches to uncovering the association of environmental stressors and 
disease outcomes, such as regression modeling, use concentrations at given time points as the 
fundamental units of analysis, but do not resolve the dynamic cyclical nature of environmental 
exposures and their metabolism. To overcome this limitation, we used recurrence quantification 
analysis (RQA) and cross-recurrence quantification analysis (CRQA), which are non-linear 
analytical methods for studying cyclical signal properties. These methods are well-characterized 
with applications in diverse scientific fields, including physiology, molecular biology, 
geophysical sciences, and psychology; for reviews, see Webber and Zbilut (35, 36) and Marwan 
et al. (37). The methods applied here, summarized in Fig. S2, are described at length in Curtin et 
al. (38) and were implemented via the Cross-Recurrence Toolbox v5.16 (39) in Matlab v2016b 
(Mathworks). Briefly, for RQA, time-series metal data from deciduous teeth were first used to 
construct recurrence plots (RPs), with delay (τ) and embedding-dimension (m) parameters 
calculated by the minimization of mutual information and false nearest- neighbors’ algorithms, 
respectively (Fig. S2). To facilitate cross-subject comparisons, threshold functions, �, were 
constrained to fix signal recurrence rates to 10%. The temporal organization of features in the 
resulting RPs was then quantified via RQA to yield measures of mean diagonal length (MDL), 
recurrence time (RT), determinism, and entropy. These measures capture different features of 
diagonal line structures in RPs, which reflect cyclical signal components. MDL quantifies the 
average duration of these cycles, while RT measures the average interval between cycles. 
Determinism compares the ratio of cyclical to non-cyclical recurrence points, and is therefore a 
unit-less metric akin to a percentage, while entropy, a unit-less metric of predictability, measures 
the variability in cyclical lengths to capture the complexity of periodic signatures. For CRQA, 
these methods are extended to cross-recurrence plots (CRPs), which capture the temporal 
organization of two signals cyclical interactions over time (35-37).  
Prior to inferential statistical tests, all variables were evaluated to confirm assumptions of 
normality in variable distributions. For analyses of recurrence features (RQA/CRQA), linear 
mixed models were used to test main effects of ASD-diagnosis on features while also testing for 
potential interactions of ASD-diagnosis and study population to evaluate population-specific 
effects. Familial relationships among subjects, including siblings and twins, were modeled as 
random variables to account for non-independence of twins and siblings, while also controlling 
for sex as a covariate. Additional covariates, including zygosity, gestational age, birth weight, and 
diagnosed comorbidities, including ADHD and intellectual disability, were also initially modeled, 
but these were ultimately excluded as they caused only negligible adjustments in our primary 
predictors and had no significant associations with outcomes. P values for study-specific 
differences reflect post-hoc analyses of ASD*Study interactions with Bonferroni adjustments for 
multiple comparisons. P values describing differences in the overall pool of subjects reflect main 
effects of ASD diagnosis with false discovery rate (FDR) P-value adjustments. 
Two classification models were undertaken; a generalization of weighted quantile sum (WQS) 
regression (21) to a binomial distribution to create a logistic classification algorithm, or the 
application of penalized logistic regression (LASSO) (40). Briefly, for WQS, data from all study 
populations were pooled and then divided into training (34% of sample size), validation (51%), 
and hold-out (15%) subsets. The training dataset was analyzed via WQS regression, yielding an 
empirically-weighted index characterizing the mixture of recurrence variables, a beta parameter 
estimating the association of this weighted index with ASD diagnosis, and an index of weights 
describing each individual variable’s contribution to the overall index. Weights derived from the 
training set were then used to construct and test a WQS index in the validation dataset, and the 
resulting beta estimates for the index were used to calculate a regression model for predicting 
outcomes in the holdout dataset, which was entirely naïve to estimation of either weights or 
regression parameters. We randomly selected participants from all the populations for the 
classification analysis so that no single study population can drive the classification accuracy (or 
specificity or sensitivity); and, significant features would be predictive independently of 
population. 
For predictive models based on penalized logistic regression, data were initially randomly subset 
into training (85% of participants) and holdout (15% of participants) datasets. As in the 
implementation of WQS, all measures derived from RQA (mean diagonal length, entropy, 
determinism, recurrence time) for all elemental pathways and cross-recurrences studied were 
included in model building. Ten-fold cross validation was then applied in the training dataset to 
identify a model with minimal deviance. The optimal LASSO model was then used to predict 
case/control status in the naïve holdout dataset. Additional details on model formulation and 
implementation are provided in the Supplementary Materials. 
In evaluating the performance of predictive classifiers, sensitivity was calculated as true positive 
predictions / number of positive cases; specificity was calculated as true negative predictions / 
number of negative cases; and, accuracy was calculated as the number of correct predictions / 
number of total predictions. We confirmed the suitability of undertaking a pooled analysis by 
establishing the equivalence of the control subjects across the four study populations (see Fig. S3, 
and Bioequivalence Testing in Supplementary Materials).  
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Fig. 1. Overview of Study Design. 
(A) Study participants recruited from Sweden (twin - co-twin discovery set), and from the US and
UK (case-control replication sets). (B) Collected deciduous teeth were analyzed using laser
ablation-inductively coupled plasma-mass spectrometry to generate temporal profiles of metal
uptake during fetal and postnatal development. (C) Example exposure profile in one subject (top
panel) ranging from -89 to 300 days since birth; dashed line indicates birth, while black arrows
indicates a period of approximately 10 days. Bottom panel shows magnified region from -39 to 56
days since birth (TSB; time since birth in days) to highlight cycles in elemental concentration
varying on a roughly 10-day period. (D) In top panel, example elemental exposure profiles in a
single subject for two elements (Zn, blue line; Cu, green line) simultaneously sampled and
overlaid from -126 to 290 TSB. Bottom panel shows magnified region from -126 to -64 TSB
showing concentration of both elements rising and falling in synchrony. (E) Recurrence plot
generated from single element trace in Panel C. This graphical analytical tool, analogous to a
spectrogram, presents cyclical processes as diagonal lines to allow the timing and distribution of
cycles to be analyzed, and contrasted with singular moments that do not repeat (represented as 
white space), points that recur only once (singular black points), or periods of stability where 
concentrations are relatively constant over time (vertical or horizontal lines); these structures are 
emphasize in the circular inset. During recurrence quantification analysis (RQA), the duration of 
cycles is captured by measuring mean diagonal length (MDL), robustness (determinism), and 
complexity (entropy).  (F) Cross-recurrence plot (CRP) for the dual element cycles presented in 
Panel D.  
Fig. 2. Disruption of Zinc-Copper Cycles in ASD Cases and Controls. 
Mean diagonal length (A), entropy (B) and determinism (C) are reduced in autism cases (squares) 
compared to controls (circles) in all study populations, indicating that zinc-copper cycles are of 
shorter duration, lower complexity and reduced regularity in cases. Pooled estimates generated by 
combining data from all studies. Data are means +/- 95% confidence intervals. 
Fig. 3. Performance of WQS-Regression and Penalized Logistic Regression Algorithms in 
Classifying ASD Cases and Controls. 
(A) ROC curve showing classification performance of the WQS algorithm with varying threshold
values applied to the holdout dataset (15% of data). AUC, area under the curve. (B) Classification
performance of a penalized logistic regression algorithm applied to a holdout dataset (15% of
data) following 10-fold cross-validation in a training dataset (85% of data).  (C) Model
performance characteristics.
Table 1. Characteristics of Study Participants. 
Study Location Design N (cases) Male:Female Mean gestational days (SD) 
RATSS Stockholm, 
Sweden 
National prospective twin 
cohort 
75 (20) 46:29 247 (24) 
ALSPAC Bristol, UK Case-control nested in 
prospective cohort 







18 (10) 12:6 258 (21) 
Autism Tooth 
Fairy Study 
Texas, USA Community based case-
control 
50 (25) 25:25 N/A 
Supplementary Materials 
Materials and Methods 
Study Populations 
We undertook this study in four geographically distinct populations. An important consideration 
for our discovery analysis was to apply control over genetic factors, which we achieved by 
comparing individuals with ASD with their discordant twin siblings and non-ASD twins in the 
Roots of Autism and ADHD Twin Study (RATSS). However, after discovery, we considered it 
important to extend our findings to non-twin siblings and unrelated participants. We also 
preferred to include participants from different geographic regions, rather than undertake 
replication in a single study. To achieve this aim, our primary criteria for inclusion were that 
children enrolled in established studies with an ASD diagnosis that required treatment by a 
medical professional, were able to provide naturally shed deciduous teeth, and had no known 
neurodevelopmental disorder or genetic syndromes. Since our analysis does not include cross-
population comparisons of diagnostic indices, we included children diagnosed with any validated 
clinical diagnostic tests for ASD. Our study has 75 discovery participants, and an additional 118 
participants for our replication analysis (Table 1).  
Roots of Autism and ADHD Twin Study (RATSS). Description of the RATSS for projects 
using teeth has been reported before (1). Participating twins in this study are part of RATSS 
recruited between 2011 and 2016 (2). The study was approved by the Swedish Regional Ethical 
Review Board and all participants gave written informed consent. Potential twin participants for 
the RATSS are identified through nationwide registries, including the Child and Adolescent Twin 
Study in Sweden (CATSS) (3), a population-based study of all twins born in Sweden since 1992 
in which all twins are screened at age nine using the Autism, Tics, ADHD and other 
Comorbidities Inventory (A-TAC). Participants are identified through linking the Swedish Twin 
Registry to other National registries such as the Swedish National Patient Register, and regional 
clinical registers in Stockholm County (Child and Adolescent Psychiatry [“Pastill”], Habilitation 
& Health Centers) that include ICD-10 diagnostic information (4, 5). Finally, potential 
participants are also identified through Swedish societies for neurodevelopmental disorders 
(NDDs) as well as advertisements and summons in the media. Even though the recruitment is 
done through different routes, >80% of the twins in RATSS are present in the Swedish twin 
registries. 
Twin pairs were recruited into the RATSS either based on discordance for ASD (>2 points 
differences on the A-TAC autism subscale equaling ~1 SD); concordance for ASD (both twins 
reaching cut-off on the A-TAC autism scale); or concordance for no NDD (both twins under cut-
offs for all NDD subscale on the A-TAC). For other sources of recruitment, the twins are invited 
if at least one twin has an ICD-10 diagnosis of autism (F84.0), Asperger syndrome (F84.5), or 
atypical autism/pervasive developmental disorder not otherwise specified (PDD-NOS) (F84.1, 
F84.8, F84.9), or a Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) 
diagnosis of ASD (either parent- or registry reported). All potential participants undergo a 
telephone interview by a research nurse checking eligibility before the invitation for assessment in 
RATSS.  Zygosity was determined by genotyping of saliva, or whole-blood derived DNA using 
standard methods. The genotyping was done using Infinium Human-CoreExome chip (Illumina 
Inc. USA). The estimating identity by descent was analyzed using the PLINK software (v1.07) (6)
after quality control and removal of SNPs with minor allele frequency less than 0.05 within the 
samples. All pairs of DNA samples showing >=0.99 were considered as monozygotic pairs. For 
few pairs, a short tandem repeat kit (Promega Powerplex 21) was used to determine the zygosity. 
Ascertainment of ASD Cases and Controls: Medical history and sociodemographic information 
of the families were collected. ASD was diagnosed according to DSM-5 criteria based on clinical 
experts consensus and corroborated by results from the Autism Diagnostic Interview – Revised 
(ADI-R) (7) and the Autism Diagnostic Observation Schedule Second Edition (ADOS-2) (8). 
Clinical severity of ASD symptoms was determined by ADOS comparison scores, and autistic 
traits were measured by parent reported Social Responsiveness Scale-2 (SRS-2) (9) total raw 
scores. General cognitive ability was assessed using the Wechsler Intelligence Scales for Children 
or Adults (Fourth Editions) or the Leiter Scales and the Peabody Picture Vocabulary Test (Third 
Edition) in cases of low verbal abilities.(10-12) Our study included both identical/monozygotic 
twins and fraternal or dizygotic. There were 34 MZ twins (17 pairs). Additional details have been 
published elsewhere (1). 
Tooth Collection and Storage: Parents/guardians collected the naturally shed deciduous teeth at 
home. Teeth were brought to the study team in person and stored at room temperature until 
analysis.  
Avon Longitudinal Study of Parents and Children (ALSPAC) 
ALSPAC is a longitudinal cohort study which recruited 14,541 pregnant women resident in Avon, 
UK with expected dates of delivery 1st April 1991 to 31st December 1992. 14,541 is the initial 
number of pregnancies for which the mother enrolled in the ALSPAC study and had either 
returned at least one questionnaire or attended a “Children in Focus” clinic by 19/07/99. Of these 
initial pregnancies, there were a total of 14,676 fetuses, resulting in 14,062 live births and 13,988 
children who were alive at 1 year of age.  When the oldest children were approximately 7 years of 
age, an attempt was made to bolster the initial sample with eligible cases who had failed to join 
the study originally. The number of new pregnancies not in the initial sample (known as Phase I 
enrolment) that are currently represented on the built files and reflecting enrolment status at the 
age of 18 is 706 (452 and 254 recruited during Phases II and III respectively), resulting in an 
additional 713 children being enrolled. The phases of enrolment are described in detail (13). The 
total sample size for analyses using any data collected after the age of seven is therefore 15,247 
pregnancies, resulting in 15,458 fetuses. Of this total sample of 15,458 fetuses, 14,775 were live 
births and 14,701 were alive at 1 year of age (study website contains details of all data available: 
http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/) (13, 14). Regular data collection is 
ongoing since September 6th 1990. Ethical approval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics Committees (listed 
at http://www.bristol.ac.uk/alspac/researchers/research-ethics/). All participants provided written informed 
consent. 
Ascertainment of ASD Cases and Controls: The identification of ASD cases in ALSPAC is 
described in detail elsewhere (15). Briefly, information of ASD diagnosis was obtained from UK 
National Health Service (NHS) and education sources. The use of multiple sources was 
implemented to ensure as complete an ascertainment as possible (16). All ALSPAC cohort 
members who had a World Health Organization’s International Statistical Classification of 
Diseases and Related Health Problems, Tenth Revision (ICD-10) diagnosis relating to any form 
of developmental delay for the period 1991 to 2003 inclusive, or those who were identified in the 
NHS Child Health computer system as having special educational needs during the same time 
period were identified, and their health records were obtained from the NHS.   
All the NHS Trusts in the ALSPAC area have specialist autism teams in children’s services, 
trained to use standardized assessment tools including the Diagnostic Interview for Social and 
Communication Disorders (17); the Autism Diagnostic Observation Schedule (18
Asperger Syndrome Diagnostic Interview (19). A team of three experienced researchers searched 
NHS hospital medical records (in-patient and outpatient) and community child health records 
(including child development team records) to identify children who had a diagnosis of ASD 
made after a multidisciplinary assessment. The researchers searched for ICD-10 diagnoses 
according to a structured proforma, based on information that was available in the records written 
by the multiprofessional team involved in the care of the child. A board-certified pediatrician with 
30 years of clinical experience reviewed all information collected from the notes and confirmed 
that the diagnostic information was consistent with ICD-10 criteria. 
In addition, the Department of Education for England Pupil Level Annual Schools Census 
(PLASC) dataset which included data on children attending state schools who were recorded as 
having some form of special educational needs was searched for ALSPAC children with ASD 
listed as either a primary or a secondary concern. 
Tooth Collection and Storage: Teeth were collected when participants were 5-7 years old. 
Mothers were asked for any teeth shed naturally or extracted by a dentist, without cavities or 
fillings, to be sent to the ALSPAC team. Mothers were asked to keep teeth at room temperature 
and to indicate the date when the tooth was shed. Approximately 70% of those contacted provided 
teeth, and those were kept at -20ºC. For this study, teeth samples from 25 ASD cases and 25 
healthy controls with no documented developmental, learning or psychiatric disorder were 
obtained for the present study. Cases and controls were matched for sex and birth weight.  
Seaver Autism Center, New York, USA 
The Seaver Autism Center is located at the Icahn School of Medicine at Mount Sinai in New 
York City and serves a diverse and complex patient population. The Seaver Center has 
longstanding community ties and receives approximately 600 new autism referrals annually for 
research and/or clinical services. Ethical approval for the study was obtained from Mount Sinai 
School of Medicine research ethics committee. All participants and/or their parents provided 
written informed consent. 
Ascertainment of ASD Cases and Controls: In 2016 we contacted all families in ongoing studies 
and services at the Seaver Center that (1) had a child with ASD as well as an additional child 
without a diagnosis of ASD, and (2) the case and sibling where of teeth-shedding age (ages 5-10). 
Informed consent was obtained from all parents or legal guardians. ASD diagnosis was confirmed 
through a gold-standard evaluation including the Autism Diagnostic Observation Schedule, 
Second Edition (ADOS-2) (20), and the Autism Diagnostic Interview-Revised (ADI-R)(21) and a 
clinical evaluation with a board-certified child and adolescent psychiatrist or licensed clinical 
psychologist to assess DSM-5 (22) criteria for ASD.  
Tooth Collection and Storage: Caregivers were provided with an individual collection kit and a 
corresponding questionnaire for each tooth. The questionnaire included the following multiple 
choice questions: (1) How was the tooth obtained? Response options: Lose and fell out naturally, 
removed by a dentist, unknown, other; (2) How was the tooth stored? Response options: Dry, in a 
plastic bag, in water, in another liquid, unknown, other.  Parents were asked to specify when 
“other” was selected. Demographic information was provided by caregivers for all probands and 
siblings. These included information on gestational age, birth weight, significant perinatal 
medical history, and psychiatric diagnoses. Teeth samples from 10 ASD cases and 8 of their 
siblings with no documented developmental, learning or psychiatric disorder were obtained for 
the present study. This sample was predominantly white American (77%).  
University of Texas Health Sciences Center, Houston, Texas, USA 
In January 2011, deciduous tooth collection was commenced in a national sample of families 
enrolled in the Interactive Autism Network (IAN). The IAN network is the nation’s largest online 
autism research forum where over 43,000 families complete comprehensive surveys and 
participate in various research studies. Inclusion criteria for IAN participants are parents with 
children under 18 years of age who have been diagnosed with ASD by a health professional. 
Twenty-five cases and 25 gender-matched controls were selected for inclusion in this study. 
Ascertainment of ASD Cases and Controls: The diagnosis of ASD in the IAN database has been 
clinically validated in a subsample of participants89 as well as verified by a review of parent- and
professional-provided medical records90. This work reports 98% concordance of validated ASD
diagnoses with parental self-report, thus supporting the viability of the centralized database 
recruitment model. Notwithstanding, to verify diagnosis in our non-IAN recruits, a certified 
diagnostician recently conducted an ADIR interview by phone in a random subset of our 
participants. We found that there was a 100% concordance between parent-reported and 
diagnostician assessed ASD. In the current study, we exclude the use of teeth from children 
whose mothers report having children with various other medical or neurological conditions 
including ADHD, and retain only those with ASD or those that are typically developing controls 
with no reported medical, emotional or psychological comorbidities. 
We have recruited unrelated population controls through television news spots, print media 
advertisement, as well as a wide consortium of community-based partners that include several 
children’s dental and well-child medical clinics. Similar to case mothers, control mothers who 
choose to participate are asked to submit one or more teeth from each of her children. While a 
potential source of controls might be obtained from families who are friends of case families, this 
is not recommended in case-control studies due to unknown inherent confounding biases.88
Tooth Collection and Storage: Potential participants contact our research coordinator who then 
screens them for eligibility. Each mother must be the biological mother of the child whose 
deciduous teeth will be provided.  If eligible, families receive a study packet in the mail 
consisting of a consent form, tooth envelope, return envelope and a survey. The survey asks 
information about family demographics, medical history, pre and postnatal care and brief 
exposure histories. For families with more than one child, separate surveys and shipping packets 
are mailed.  
When the material is returned (we currently have a 90 % return rate from eligible families 
requesting a packet), each survey and tooth is then given a unique study identification number 
that links surveys to teeth. Both teeth and survey data are entered into our database and stored in 
locked file cabinets until they are selected for analysis. For both case and control teeth, we utilize 
canine, molar and incisor teeth without cavities or fillings. We matched the case and controls in 
this study by gender and approximate age (within a 5-year range). Teeth are stored at room 
temperature until analysis. 
Bioequivalence Testing 
For bioequivalence testing of RQA/CRQA measures of control subjects across populations, we 
extended standard equivalence testing methods following the principles of confidence interval 
inclusion14. These provide confidence intervals (CIs) on the comparative ratios of population
means for a given measure, with equivalence inferred from containment of family-wise CIs 
within a pre-defined equivalence bound; here, as per FDA guidelines (FDA-CDER, 2003)(23), 
ranging from 0.80 - 1.25. Asymmetric confidence intervals were constructed by back-
transforming confidence intervals from Dunnett’s test (with family-wise 95% confidence 
coefficient, with the discovery cohort as reference) on the difference of logs constructed using 
least square means adjusted for covariates (here, sex) in a general linear model of each log-
transformed measure. Analyses were conducted using PROC GLM in SAS (v.9.4).  
Statistical Models 
Linear mixed models were used to test for global and population-specific effects of ASD 
diagnosis on dynamical features measured with RQA, e.g. mean diagonal length (MDL), entropy, 
determinism. These models followed the equation: , where y is an RQA feature 
(e.g., MDL), Xβ reflects fixed effects and associated observations,  reflects a design matrix and 
associated random effect to account for the relatedness, and therefore potential non-independence, 
of subjects (twins, siblings, or unrelated), with  as a vector of random errors. The primary fixed 
effects relating to our study question were ASD (diagnosis as case or control), to test for global 
(across study) differences in ASD, and an ASD*Study interaction, to test for population-specific 
differences in ASD, with sex included as a covariate. Additional covariate variables, including 
zygosity of twins, diagnosed comorbidities, gestational age at birth, birth weight, and diagnosed 
comorbidities were initially modeled but were ultimately excluded, as these caused only 
negligible adjustments in associations with our primary predictors and had no significant 
associations with outcomes. For all models, P values related to main hypotheses (ASD effect, 
ASD*Study interaction) are reported following FDR adjustment for multiple comparisons; these 
are reported in Table S4. Where study-specific post-hoc tests were conducted, all P values 
reported reflect model-specific Bonferroni adjustment. 
For classification with penalized logistic regression, a LASSO model was implemented as per 
Tibshirani (24). The objective function for this was: 
A selection parameter, α, was fixed at 1 for the LASSO procedure, with outcome (ASD case or 
control) y, model intercept β0, shrinkage parameter   the matrix of predictor variables and 
associated beta estimates, and  the L1 norm regularization term.  The predictor variables in 
the model included all RQA features derived from single-element and dual-element (cross-
recurrence) analyses. The glmnet package (v2.0-13) in R was used to implement the model. 
Supplementary Table 5 lists the features that survived shrinkage during cross-validation of the 
model, and their associated parameter estimates.  
For weighted quantile sum (WQS) regression, models followed the form: 
Here, β0  indicates the model intercept, z’ and  indicate a vector of covariates and associated 
regression parameters, and β1  reflects the regression parameter (β1) and weighted quantile 
sum index ( ), where wi indicates the estimated weight for each predictor variable and qij 
reflects the ranked (here, quartiles) measure per subject; the summation of these terms  (wiqij) 
provides the weighted quantile sum index. A link function, g(µ), allows the generalization of this 
equation to multiple distributions; for classification, as in this study, the logit link to the binomial 
distribution was used, i.e. , where µ is the probability of a subject diagnosed as an ASD 
case. All parameters, including weights, are estimated via maximal likelihood estimation, where 
final weights are averaged across 100 bootstrapped samples, with weights constrained to vary 
between 0-1, and to sum to 1.  
During model training, a subset of the data are used to estimate weights for each variable, which 
are then used to calculate and test a WQS index in the validation dataset. The weights (training 
set) and parameter estimates (validation set) from these models are then applied for prediction in 
the naïve data in the holdout dataset. Model fit and variable weights from WQS regression are 
provided in Supplementary Figure 4. 
Results 
Population-Independent Properties of Zinc-Copper Cycles 
It is possible that highly evolved zinc-copper cycles have consistent properties within a species 
and, therefore, would show small variances across geographic populations, similar to other 
physiologic set points such as normal body temperature or blood pressure. We were able to test 
whether copper-zinc cycles are population independent using an equivalence testing approach 
(25). This statistical method is commonly used to test for bioequivalence between the efficacy of 
pharmaceuticals (25). We found that for all three measures of zinc-copper rhythmicity, the four 
different populations tested were bioequivalent (Fig. S3).  
Dysregulation of Other Elemental Cycles 
Earlier work has shown that lead exposure is associated with autism risk (26), and zinc is known 
to be protective against the toxic effects of lead in animal models (27). We observed that ASD 
cases exhibited zinc-lead cycles that were different to their non-ASD counterparts (Fig. S1 and 
Table S1). As with the zinc-copper cycles, overall cases displayed reduced determinism 
(P<0.001) and entropy (P<0.05), and tended to exhibit reduced MDL (P=0.06), but these 
differences were not consistent across populations, particularly for determinism.  
As an exploratory analysis, we also examined cycles of individual elements (Table S2). We found 
that copper rhythms were elongated (higher mean diagonal length, P=0.002) in ASD cases and 
showed greater complexity (increased entropy, P=0.001) and determinism (P=0.002) in ASD 
cases compared to controls. Copper rhythms in ASD cases also tended to have a smaller time gap 
between cycles, as indicated by a reduction in recurrence time type 2 (P=0.004). A reversal in 
these trends was evident for lithium, where cases showed rhythms that were shorter (P=0.04), less 
complex (P=0.049) and unstable (P=0.022) for lithium and had reduced determinism lead 
(P=0.022).  
















Statistically non-significant reductions in mean diagonal length (A), entropy (B) and determinism 
(C) are observed in autism cases (squares) compared to controls (circles) in all study populations.
Data are means +/- 95% CI. Pooled estimates generated by combining data from all studies.
Fig. S2. Recurrence Quantification Analysis. 
(A) Developmental exposure profile for Ca, expressed as counts, reflecting elemental
concentrations in tooth matrices at approximately 100 sequential sampling points that reflect a
time period from the second trimester to birth. (B) Delay embedding of the signal in (A), showing
the paneled-section of the waveform. The original signal is shown in blue, with green and red
lines reflecting two embeddings (time-lagged duplicates) of delay (τ) 10. (C) Phase-portrait of the
Ca time-series in (A) plotted in three-dimensions. The coordinates of a given point are determined
by the value of each delay-embedded signal at that time interval.  Black circle indicates an
exemplar threshold (ε) used to construct a recurrence matrix (shown in D). (D) Recurrence plot of
the Ca time-series. Black marks in matrix indicate time-points where the system entered a given
state (within-threshold on phase-portrait); e.g., all black marks vertical of day 20 indicate times
when the system returned to the state it was in at day 20. Diagonal structures in this plot reflect
periods of stable cyclical orbits, while white space indicates unique values, and laminar structures
(vertical/horizontal lines) reflect static states. During recurrence quantification analysis (RQA),
the duration and distribution of cyclical periods are quantified. Note this figure appears also in the
supplementary materials to Curtin et al. (2017).
Fig. S3. Equivalence Testing of Control Group Means Across Studies. 
Asymmetric family-wise 95% confidence intervals (based on Dunnett comparisons) on cross-
recurrence measures for the ratio of study means (S1/S2, S1/S3 and S1/S4) of control groups, 
adjusted by sex. S1: Sweden, S2: Texas, S3: NY, and S4: UK. When the two family-wise 
confidence intervals are contained in the equivalence bounds of 0.8, 1.25 (shaded region), the four 
study means for the specified cross-recurrence are equivalent. 
Fig. S4. Model Fit and Weight of Variables Contributing to the Weighted Quantile Sum (WQS) 
Regression Model. 
(A) Model fit in the validation dataset. Performance metrics describe classification error in the
validation dataset (51% of data), from which regression parameters are estimated. (B) Variable
weights extracted from the training dataset (34% of data).
Table S1. Results of Cross-Recurrence Analyses. 
Values in the table reflect P values from linear mixed models regressing the effect of ASD-
diagnosis (Pooled column; FDR-adjusted main effect of ASD) and study-specific posthoc tests 
(Bonferroni-adjusted for multiple comparisons) comparing measures between ASD cases and 
controls within an ASD*Study interaction. 







Determinism 0.001 <0.001 0.03 0.063 <0.001 
Mean Diagonal 
Length 
<0.001 0.029 0.005 0.023 <0.001 
Entropy <0.001 0.003 0.003 0.037 <0.001 






Determinism <0.001 1 1 1 <0.001 
Mean Diagonal 
Length 
0.25 1 1 .43 0.061 
Entropy 0.067 1 1 .46 0.048 








Determinism 1 1 1 1 0.73 
Mean Diagonal 
Length 
0.69 1 1 1 0.81 
Entropy 1 1 1 1 0.65 
Recurrence Time 1 0.82 0.70 1 0.18 
Table S2. Results of Single Recurrence Analyses. 
Values in the table reflect P values from linear mixed models regressing the main effect of ASD-
diagnosis (Pooled column; FDR-adjusted main effect of ASD) and study-specific posthoc tests 
(Bonferroni-adjusted for multiple comparisons) comparing measures between ASD cases and 
controls within an ASD*Study interaction. 





Determinism 0.99 0.007 0.46 1 0.002 
Mean Diagonal 
Length 
0.4 0.037 0.63 0.27 0.002 
Entropy 0.47 0.019 0.46 0.16 0.001 






Determinism 0.038 0.44 1 1 0.022 
Mean Diagonal 
Length 
0.059 1 0.34 1 0.04 
Entropy 0.066 1 0.67 1 0.049 




Determinism 1 1 0.94 0.012 0.022 
Mean Diagonal 
Length 
0.59 1 1 0.24 0.18 
Entropy 0.64 1 1 0.15 0.13 




Determinism 1 0.80 1 1 0.44 
Mean Diagonal 
Length 
1 0.65 0.78 1 0.21 
Entropy 1 0.70 1 1 0.39 
Recurrence Time 0.45 0.34 1 1 0.13 
Table S3. Laser Ablation Analysis of Teeth. 
NWR-193 Laser Conditions Agilent 8800 ICP-MS Conditions 
Wavelength (nm) 193 RF power (W) 1350 
Helium carrier flow (L min
-1





) 5.0 Plasma gas flow (L min
-1
) 15 
Repetition rate (Hz) 10 Sample Depth (mm) 4.0 
Spot size (μm) 35 Scan mode Peak hopping 
Scan speed (μm s-1) 35 Integration time (ms) 50 – 55 





Effect F Value FDR 
adjusted P
Zn_Cu Determinism ASD 47.99 7.74E-07
ASD*Study 2.56 0.072
Zn_Cu Entropy ASD 57.3 1.18E-07
ASD*Study 1.98 0.140
Zn_Cu Mean_DL ASD 52.25 2.63E-07
ASD*Study 3.83 0.014
Zn_Cu RT2 ASD 4.64 0.072
ASD*Study 1.77 0.189
Cu Determinism ASD 15.51 0.002
ASD*Study 4.25 0.008
Cu Entropy ASD 18.2 0.001
ASD*Study 5.32 0.002
Cu Mean_DL ASD 15.6 0.002
ASD*Study 6.51 0.001
Cu RT2 ASD 12.46 0.004
ASD*Study 3.85 0.014
Zn_Pb Determinism ASD 30.21 1.93E-05
ASD*Study 12.39 8.64E-07
Zn_Pb Entropy ASD 5.84 0.048
ASD*Study 0.93 0.552
Zn_Pb Mean_DL ASD 5.03 0.061
ASD*Study 1.4 0.295
Zn_Pb RT2 ASD 5.05 0.061
ASD*Study 21.68 2.10E-09
Pb Determinism ASD 7.8 0.023
ASD*Study 2.42 0.076
Pb Entropy ASD 3.18 0.131
ASD*Study 2.65 0.061
Pb Mean_DL ASD 2.46 0.180
ASD*Study 2.99 0.044
Pb RT2 ASD 0.45 0.567
ASD*Study 0.87 0.567
Zn_Li Determinism ASD 0.15 0.725
ASD*Study 2.86 0.048
Zn_Li Entropy ASD 0.26 0.649
ASD*Study 1.43 0.289
Zn_Li Mean_DL ASD 0.06 0.811
ASD*Study 2.47 0.072
Zn_Li RT2 ASD 2.5 0.179
ASD*Study 1.3 0.338
Li Determinism ASD 7.91 0.022
ASD*Study 2.26 0.096
Li Entropy ASD 5.65 0.050
ASD*Study 2.18 0.106
Li Mean_DL ASD 6.43 0.040
ASD*Study 1.47 0.278
Li RT2 ASD 0.41 0.567
ASD*Study 0.56 0.772
Zn Determinism ASD 0.81 0.436
ASD*Study 1.68 0.204
Zn Entropy ASD 0.98 0.392
ASD*Study 4.9 0.003
Zn Mean_DL ASD 2.06 0.213
ASD*Study 5.95 0.001
Zn RT2 ASD 3.14 0.131
ASD*Study 10.5 5.20E-06
For each elemental pathway or cross-recurrence (column 1), the effects of ASD diagnosis or an 
ASD*Study interaction (rows in effect column) were tested on 4 RQA features. Test statistics and 
FDR-adjusted P values are given for each effect. FDR adjustment reflects the 56 tests done across 
all pathways and effects listed. 
Table S5. Features Preserved in the Penalized Logistic Regression Classifier. 
Elemental pathway RQA Feature Beta
Cu Determinism 2.0604
Cu Entropy 4.0472
























Zn_Pb Mean Diagonal Length .
Zn_Pb RT2 .
All features included during cross-validation and prediction are listed by elemental pathway 
(column 1) and dynamical feature extracted via recurrence quantification analysis (RQA) or 
cross-recurrence quantification analysis (CRQA) (column 2). Associated beta estimates are 
provided in column 3, with blank values (.) indicating features zeroed during LASSO shrinkage. 
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